Application of a new single-cell immunoassay reveals IL-2 and IFN-γ secretion in Jurkat T cells, indicating cancer subtype effects.
Studying the characteristics of T cell activation and cytokine secretion is crucial for understanding the cell-mediated immunological response (CMI). To assess this purpose, we present a droplet-based single-cell immunoassay platform, named Drop-SCIA, which uniquely integrates surface-enhanced Raman spectroscopy (SERS) with homogeneous-phase immunoassay, enabling highly sensitive, multiplexed cytokine detection at the single-cell level and offering superior target enrichment efficiency compared to the widely used interface-based ELISpot assay. Using this platform, we analyzed Jurkat T cell activation and further profiled IL-2 and IFN-γ secretion following coculture with normal breast epithelial cells (MCF-10A) and breast cancer subtypes (MCF-7, MDA-MB-231). The platform enables robust and reliable single-cell immune profiling of Jurkat cells, allowing precise assessment of their activation status. Significant differences in IL-2 and IFN-γ secretion were observed under different coculture conditions, indicating that distinct breast cancer subtypes exert differential effects on T cell activation and function. By combining microdroplet microfluidics with SERS-based signal readout, Drop-SCIA represents a significant technological advancement in the study of CMI within tumor microenvironments. It will aid in the precise analysis of T-cell immune function for vaccine development, cancer immunotherapy, and the diagnosis and treatment of viral and other infectious diseases.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: